These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Rat erythrocyte NADH-cytochrome b5 reductase. Quantitation and comparison between the membrane-bound and soluble forms using an antibody against the rat liver enzyme. Borgese N, Macconi D, Parola L, Pietrini G. J Biol Chem; 1982 Nov 25; 257(22):13854-61. PubMed ID: 7142181 [Abstract] [Full Text] [Related]
24. Analysis of mutant NADH-cytochrome b5 reductase: apparent "type III" methemoglobinemia can be explained as type I with an unstable reductase. Nagai T, Shirabe K, Yubisui T, Takeshita M. Blood; 1993 Feb 01; 81(3):808-14. PubMed ID: 8427971 [Abstract] [Full Text] [Related]
29. Cytochrome b5/cytochrome b5 reductase complex in rat liver microsomes has NADH-linked aquacobalamin reductase activity. Watanabe F, Nakano Y, Saido H, Tamura Y, Yamanaka H. J Nutr; 1992 Apr 01; 122(4):940-4. PubMed ID: 1552368 [Abstract] [Full Text] [Related]
30. [Leu 72 Pro mutation in the NADH-cytochrome b5 reductase gene found in a Chinese hereditary methemoglobinemia patient]. Wu Y, Huang C, Zhu Z. Zhonghua Xue Ye Xue Za Zhi; 1998 Apr 01; 19(4):195-7. PubMed ID: 11243135 [Abstract] [Full Text] [Related]
33. An in-frame deletion of codon 298 of the NADH-cytochrome b5 reductase gene results in hereditary methemoglobinemia type II (generalized type). A functional implication for the role of the COOH-terminal region of the enzyme. Shirabe K, Fujimoto Y, Yubisui T, Takeshita M. J Biol Chem; 1994 Feb 25; 269(8):5952-7. PubMed ID: 8119939 [Abstract] [Full Text] [Related]
34. The structure and biochemistry of NADH-dependent cytochrome b5 reductase are now consistent. Bewley MC, Marohnic CC, Barber MJ. Biochemistry; 2001 Nov 13; 40(45):13574-82. PubMed ID: 11695905 [Abstract] [Full Text] [Related]
35. Seven new mutations in the nicotinamide adenine dinucleotide reduced-cytochrome b(5) reductase gene leading to methemoglobinemia type I. Dekker J, Eppink MH, van Zwieten R, de Rijk T, Remacha AF, Law LK, Li AM, Cheung KL, van Berkel WJ, Roos D. Blood; 2001 Feb 15; 97(4):1106-14. PubMed ID: 11159544 [Abstract] [Full Text] [Related]
36. Two novel mutations in the reduced nicotinamide adenine dinucleotide (NADH)-cytochrome b5 reductase gene of a patient with generalized type, hereditary methemoglobinemia. Manabe J, Arya R, Sumimoto H, Yubisui T, Bellingham AJ, Layton DM, Fukumaki Y. Blood; 1996 Oct 15; 88(8):3208-15. PubMed ID: 8874222 [Abstract] [Full Text] [Related]
37. Membrane-bound cytochrome b5 reductase (methemoglobin reductase) in human erythrocytes. Study in normal and methemoglobinemic subjects. Choury D, Leroux A, Kaplan JC. J Clin Invest; 1981 Jan 15; 67(1):149-55. PubMed ID: 7451647 [Abstract] [Full Text] [Related]
39. High-level expression in Escherichia coli of the soluble, catalytic domain of rat hepatic cytochrome b5 reductase. Barber MJ, Quinn GB. Protein Expr Purif; 1996 Aug 15; 8(1):41-7. PubMed ID: 8812833 [Abstract] [Full Text] [Related]
40. Alternative RNA splicing of the human endothelin-A receptor generates multiple transcripts. Miyamoto Y, Yoshimasa T, Arai H, Takaya K, Ogawa Y, Itoh H, Nakao K. Biochem J; 1996 Feb 01; 313 ( Pt 3)(Pt 3):795-801. PubMed ID: 8611157 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]